{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
Nisco Engineering AG was founded on the 6th of July 1996. The company is located in Zurich, Switzerland and has Quality Management System according ISO 9001:200x. since 1997. Nisco offers encapsulation systems since 1999 to produce monodisperse microbeads between 20 micro meters and 5mm.
A Zurich-based corporate finance firm committed to advancing the life science field through advisory and capital raise.
Maintenance-free cell culture analyzer technology, BioProfile FLEX2. With autosampling from ambr® 15 and 250 cell culture systems, FLEX2 provides key chemistries and gases, cell density, viability, and osmolality with single sample and data output stream.
At OBaris, we are revolutionizing peptide drug delivery with OctoPatch®—a painless, patient-friendly platform designed to replace injections. Our innovative technology enables pharma partners to target various diseases, improving patient compliance and treatment outcomes.
OxyPrem AG is the manufacturer of OxyPrem 1.4, a novel non-invasive tissue oximeter to determine oxygen saturation in human tissue. Its unmatched precision and reliability allow clinicians to make better decisions when assessing tissue or body parts which are at risk of oxygen under- or oversupply.
PolyGene is a private transgenic service and R&D company. We offer generation of tailor-made cellular and animal models (mice, rats and rabbits) of human disease for preclinical development and target validation, incl. consulting, vector cloning, cell culture, micoinjection and breeding.
Our vision is to make functional imaging accessible for people worldwide and create a lasting social impact. We advance clinical routine and enable research in diagnostics, treatment monitoring and the development of new therapies. Positrigo makes functional imaging scalable – imaging everyone!
Empower quality for business and society.
Founded in 2024 in Zurich, QPillars partners with biotech and medtech companies to build custom software solutions for instrument control, lab automations, data analysis. Our team of of former Olympiad medalists in informatics and physics delivers fast, reliable, and regulatory-ready solutions.
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents.
Founded in 2006, Redalpine is a leading European Venture Capital investor based in Switzerland with offices in Zurich and Berlin. The fund has more than CHF 1bn in Assets under Management and invests in ICT and Life Sciences, with a highly disciplined and sector-agnostic approach.
Redbiotec was founded in 2006 as an ETH spin-off. Having sold its CMV vaccine business to Pfizer in 2015, Redbiotec has since developed potent HSV-2 immunotherapies, and a platform technology of engineered bacteria - BRISPR® - to deliver therapeutic cargos of various nature for the treatment of cancer and ge
regulanet® Switzerland is a networking group comprised of professionals from 14 European countries focused on establishing quality systems and licenses for pharmaceutical companies.
Resmonics' mission is to unlock the power of sound for medicine. Our product ResGuard Med is a CE-certified medical software that uses acoustic artificial intelligence to detect lung symptoms and assess their severity.
Rivia is a unified data and AI analytics platform for biotech clinical trials. Rivia integrates fragmented trial data and turns it into actionable insights, to drive more predictable operations and unlock hidden therapeutic potential. Know Better. Act Better.
Next generation microbiology for water and food safety. rqmicro’s separation and detection technology for microbiological tests in the water and food industry delivers reliable, quantitative and cost-effective results in less than 2 hours.
SATW is a network of experts in engineering sciences fostering innovation and competitiveness of the Swiss economy. SATW identifies promising technologies, informs politicians and decision makers as an honest information broker and encourages young women to pursue a career in a technical field.
scienceindustries, the Swiss Business Association Chemistry Pharma Life Sciences, supports some 250 member companies: fostering an innovation-friendly environment, creating a competitive production and business framework, enabling attractive market conditions, and facilitating global market access.
Smart sensor solutions - Increase health, improve energy efficiency, ensure safety & comfort – for a better tomorrow.
The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
At Sleepiz, we believe that remote monitoring has tremendous potential to improve standards of care. That's why we're breaking new ground by transitioning from traditional wearables to contactless surveillance.
SuSoS AG is active in the field of surface modification and characterization. Our coating products and surface analytical services are directed toward those customers who face surface-related issues and/or require further development in order to improve the outermost extremities of their products.
Swiss Bioscience was established in 2014 in Switzerland and is specialized in producing pharmaceutical quality grade stems cells under cGMP* conditions. The cells are isolated from human adipose tissue to produce SVF which is then purified and expanded to produce hADSCs.
Swisslinx is a privately owned company offering headhunting and recruiting services. Established in 1999 we have offices in Basel, Zürich, Dubai and Warsaw. The Healthcare & Life Sciences team focus on roles in the commercial, technology and corporate business units of our clients.
We are Swiss leader for cutting-edge products in the life science field. Through a continuous development we offer the newest FISH, NGS, microarray, flow cytometry products and corresponding lab equipment.
Target BioScience AG is a consulting and service company engaged in market access, regulatory affairs and quality systems for pharmaceuticals and biotechnology products. Target BioScience AG has regulatory authorization to register and market pharmaceutical products in Switzerland.
Tecan is a leading global provider of laboratory instruments and solutions in life science research and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences.
TFS Trial Form Support AG is a fully owned subsidiary of TFS Health Science We cover the entire clinical development spectrum, from early-stage PoC trials, phase 1/2 studies to extensive phase 3 trials. We provide single or full services as well as resourcing of workforce.
THE CULTURED HUB works with a global network of start-ups to find answers to the food industry’s most pressing questions in order to define the food of the future. We are a scale up as a service company for industrial biotech, accelerating the development of sustainable foods through biotech.
The Venture Kick philanthropic initiative provides up to CHF 150k in seed funding to Swiss startups and offers a well-structured entrepreneurial path toward building a winning business. Winners are eligible for a CHF 850k investment from the Kickfund and an additional InnoBooster grant of CHF 150k.
Our free programs help startups close financing and accelerate global business growth. Courses include Venture Kick; the Venture Leaders life sciences roadshow to Boston; and on behalf of the government, Innosuisse training – 5 days focusing on biotech business creation (Basel) & growth (Lugano).
VERAXA is a Swiss/German clinical-stage company advancing next-generation antibody therapies to fight cancer through groundbreaking innovations. Using a dual-targeting approach, our BiTAC-TCE, BiTAC-ADC, and bsADC platforms are powered by proprietary chemical bioconjugation and linker technologies.
Versantis is a clinical-stage company developing transformative orphan drugs that fill the medical gap in the care of liver and pediatric diseases. It has been acquired by GENFIT in 2022.
VIO Chemicals is a technological innovation driven chemical company that creates complete solutions, from idea to market. With core competencies in process and product custom design, development and production, VIO Chemicals provides a full range of services to the pharma and biotech industries.
Volpi is specialized in optical-based measurement systems for life sciences and in-vitro diagnostics. Volpi is a one-stop shop that provides development, manufacturing and life cycle management. ISO 13485 certified. Swiss engineering and manufacturing excellence are combined with US manufacturing.
YugaCell provides specialized solutions in multiomics, single-cell technologies, immune repertoire profiling, and artificial intelligence/statistics to tackle the challenging R&D projects. We do so with commitment, clarity, conscience and clean code. We work as your partners, shoulder to shoulder.
As a Partner for business innovation, Zühlke develops products, services and new business models including sophisticated health tech solutions. We inspire our customers with outstanding interdisciplinary solutions in the fields of medical devices, IVD and eHealth.